As biologics gain greater prominence, protein engineers are adapting to new indications, new advances in targeting science, new product formats, and products that are truly differentiated in the marketplace. The Protein Engineering & Development pipeline offers a weeklong exploration of state-of-the-art approaches for developing safe and effective protein and antibody-based therapeutics, including improving product qualities, enhanced target specificity, and next-generation approaches to target discovery.

Conferences Include:

1月8日 - 9日

Recombinant Protein Therapeutics ( 重组蛋白质疗法 )

1月9日 - 10日

Enhancing Antibody Binding and Specificity( 抗体结合与专一性强化 )

1月11日 - 12日

Emerging Technologies for Antibody Discovery ( 发现抗体的最新技术 )